ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #557Top JournalHybrid

Cancer Immunology Research

Abbreviation (ISO):CANCER IMMUNOL RES
•
Identifier (ISSN):2326-6066(Print)/2326-6074(Online)
•
Publisher:American Association for Cancer Research Inc.
Clarivate IF (2026)
7.9↓ -0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Immunology Research

WoS Q1
5912169.1920188.6220198.73202011.2202112.0202210.120238.120248.220257.92026
Annual Impact Factor Metric
Current (2026):7.9
Scopus SJR & RankScopus Q1
3.48
#557

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
157

157 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
111articles/year
32.68% Gold OA•93.52% Original Research

Aims & Scope

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes. Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

Topics Covered (Recognized by AI)
Medicine95.3%Biology94.6%Genetics93.8%Immunology91.2%Internal medicine89.8%Immune system87%Cancer82.3%Chemistry79.3%Cancer research79.1%Biochemistry78.2%Immunotherapy68.5%Antigen52%In vitro44.4%Cytotoxic T cell38.1%T cell37.9%CD834.8%Gene33.5%Cancer immunotherapy33.4%Receptor29.8%Tumor cells27.5%Pathology26.2%Tumor microenvironment24.7%Antibody23.7%Cell biology23.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q1
Rank22/183
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q1
Rank45/333
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q1
Rank16/183
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank33/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7.9
Articles / Year366
Total Citations96
2025
IF8.2
Articles / Year451
Total Citations805
2024
IF8.1
Articles / Year271
Total Citations1,750
2023
IF10.1
Articles / Year234
Total Citations2,570
2022
IF12.02
Articles / Year363
Total Citations4,607

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #557Scopus Q1SCImago Profile
Scopus Coverage:2013-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology
Scopus Citation Rank (SJR)Q1
3.48

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.65

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,219 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,946
3-Year Documents386
Citable Documents371

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
ImmunologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Immunology Research (abbr: CANCER IMMUNOL RES, ISSN: 2326-6066) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by American Association for Cancer Research Inc. in United States. The periodical holds a Journal Impact Factor (JIF) of 7.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.480 (Q1), an H-index of 157.

The journal enforces rigorous peer evaluation with an annual output of approximately 111 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,219 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c0bd95c0-60f0-40c8-a2c0-4c422728af87
Database Updated: 2026-10-01